Quoting from CBSA Pres/CEO's recent interview with w3w3.com's Larry Nelson on the upcoming Rocky Mountain Life Science Investor and Partnering Conference (RMLIPC) in Denver:
"The Bio and Life Sciences industry faces huge challenges raising venture capital in a difficult economy. Investing in an industry that takes ten to twelve years and over $1.3 Billion to bring a drug to market just might shift the action to some widget or a software program that can be flipped to realize a return in just six months. That's the challenge facing the Colorado BioScience Association (CBSA) and president/CEO, Holli Riebel. 'Also,' she said, 'venture capitalists reside more on the coasts, and so we're always having a more difficult time attracting venture capital out here in the middle of the country.'"
Link to w3w3.com
Link to download the podcast